Temodar Capsule
Product Images NDC 0085-3004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Temodar (NDC 0085-3004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Temodar 01)

Chemical Structure (Temodar 01)
Chemical structure of Temozolomide, the active ingredient in TEMODAR injection. The diagram shows the molecular arrangement including functional groups and ring structures typical to the compound.*
FDA Label Image

Figure 1 (Temodar 02)

Figure 1 (Temodar 02)
A Kaplan-Meier survival curve chart comparing overall survival probability over time (months) from randomization between two treatment groups: RT Only and RT + TMZ for the ITT population. The chart includes a hazard ratio (HR) of 0.63 with 95% confidence interval (0.52-0.75) and a log-rank P-value less than 0.0001.*
FDA Label Image

Principal Display Panel (5 mg Capsule Sachet Carton)

Principal Display Panel (5 mg Capsule Sachet Carton)
Packaging label for Temodar (temozolomide) capsules, 5 mg strength. The label indicates oral administration and prescription use only. The package contains 5 individual sachets, each with one 5 mg capsule. Labeler is Merck Sharp & Dohme Corp. The design features a gradient background with green and blue tones and includes dosage instructions and storage conditions.*
FDA Label Image

Principal Display Panel (20 mg Capsule Sachet Carton)

Principal Display Panel (20 mg Capsule Sachet Carton)
Packaging label for Temodar (temozolomide) capsules, 20 mg strength, for oral administration. The label indicates the product contains 5 individual sachets, each with one capsule. The label includes storage information, manufacturer details (Merck Sharp & Dohme Corp.), and a barcode.*
FDA Label Image

Principal Display Panel (100 mg Capsule Sachet Carton)

Principal Display Panel (100 mg Capsule Sachet Carton)
Temodar 100 mg capsules packaging label for oral administration by Merck Sharp & Dohme LLC. The label states the capsules contain 100 mg temozolomide each, and the package includes 5 individual sachets with one capsule each. The label specifies Rx only and storage instructions at 25°C with permitted excursions. Manufacturer details and barcodes are also visible.*
FDA Label Image

Principal Display Panel (140 mg Capsule Sachet Carton)

Principal Display Panel (140 mg Capsule Sachet Carton)
Box label for Temodar (temozolomide) capsules, 140 mg strength, by Merck Sharp & Dohme LLC. The label states for oral administration, prescription only, with each package containing 5 individual sachets. Each sachet holds one 140 mg capsule. Storage instructions and warnings about capsule handling are included. Barcodes and NDC 0085-1425-03 are shown.*
FDA Label Image

Principal Display Panel (180 mg Capsule Sachet Carton)

Principal Display Panel (180 mg Capsule Sachet Carton)
Packaging label for Temodar (temozolomide) capsules, 180 mg strength, for oral administration. The box states it contains 5 individual sachets, each with one capsule. Label shows prescription use (Rx only) and provides storage conditions and warnings. Manufactured by Merck Sharp & Dohme LLC.*
FDA Label Image

Principal Display Panel (250 mg Capsule Sachet Carton)

Principal Display Panel (250 mg Capsule Sachet Carton)
Packaging label for Temodar (temozolomide) Capsules 250 mg for oral administration. The box indicates each capsule contains 250 mg temozolomide, with 5 individual sachets each containing one capsule. The labeler is Merck Sharp & Dohme LLC, and storage instructions specify 25°C with permitted excursions.*
FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
Packaging label for Temodar (temozolomide) 100 mg vial for intravenous injection, manufactured by Merck Sharp & Dohme LLC. The label specifies single-use vial, refrigerated storage at 2-8°C, and instructions to discard after use. Active ingredients, storage, and handling instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.